Ep. 5 - TrumpRx Expansion, FTC Pressure and the Growing Push for PBM Transparency

Episode notes

Mike and Madison discuss TrumpRx's expansion to include more than 600 generic drugs, Optum Rx's latest pharmacy transparency announcement and what potential Federal Trade Commission action against PBMs could mean for plan sponsors. Register for upcoming Employers Health webinars or watch on demand at

• Ep. 6 - The CVS and FTC Settlement: What it Means for Plan Sponsors80 / 100
• Ep. 5 - Claim Adjudication and Reconciliation: Key Concepts Plan Sponsors Should Know65 / 100
• Episode 64 - How Bath & Body Works Approaches Open Enrollment for a Large Workforce
• Episode 63 - Zerigo Health and At-Home Phototherapy: Better Chronic Skin Condition Outcomes at a Lower Cost
• Episode 62 - A Conversation with the 2026 Employers Health Excellence in Benefits Award Winner